Awaiting development: Guidance and quality standards
Showing 1 to 2 of 2
| Title | Type |
|---|---|
| Iptacopan for treating complement 3 glomerulopathy in people 12 to 18 years [TSID12315] | Technology appraisal guidance |
| Iptacopan for treating primary IgA nephropathy [ID6640] | Technology appraisal guidance |